Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.042x

Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥239.54 Million ≈ $35.05 Million USD) by net assets (CN¥5.66 Billion ≈ $827.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yantai Dongcheng Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Yantai Dongcheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
0.008x
Qisda Corp
TW:2352
-0.072x
Devyani International Limited
NSE:DEVYANI
0.095x
Minera Valparaiso S.A.
SN:MINERA
0.026x
Beijing Lier High Temperature Materials Co Ltd
SHE:002392
0.010x
Healthcare Services Group Inc
NASDAQ:HCSG
0.085x
DOMS Industries Limited
NSE:DOMS
0.046x
Domain Holdings Australia Limited
F:3DH
0.011x

Annual Cash Flow Conversion Efficiency for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 002675 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.66 Billion
≈ $827.65 Million
CN¥584.61 Million
≈ $85.55 Million
0.103x +93.35%
2024-12-31 CN¥5.37 Billion
≈ $786.01 Million
CN¥287.15 Million
≈ $42.02 Million
0.053x +4.15%
2023-12-31 CN¥5.40 Billion
≈ $789.55 Million
CN¥276.94 Million
≈ $40.53 Million
0.051x -72.79%
2022-12-31 CN¥5.28 Billion
≈ $772.97 Million
CN¥996.54 Million
≈ $145.82 Million
0.189x +0.44%
2021-12-31 CN¥5.02 Billion
≈ $735.14 Million
CN¥943.58 Million
≈ $138.08 Million
0.188x +62.89%
2020-12-31 CN¥4.97 Billion
≈ $726.63 Million
CN¥572.58 Million
≈ $83.79 Million
0.115x -20.87%
2019-12-31 CN¥4.78 Billion
≈ $699.31 Million
CN¥696.38 Million
≈ $101.90 Million
0.146x +36.26%
2018-12-31 CN¥4.61 Billion
≈ $674.68 Million
CN¥493.06 Million
≈ $72.15 Million
0.107x +68.33%
2017-12-31 CN¥3.29 Billion
≈ $481.25 Million
CN¥208.94 Million
≈ $30.57 Million
0.064x -0.18%
2016-12-31 CN¥3.08 Billion
≈ $451.28 Million
CN¥196.28 Million
≈ $28.72 Million
0.064x +113.39%
2015-12-31 CN¥2.24 Billion
≈ $327.19 Million
CN¥66.69 Million
≈ $9.76 Million
0.030x -32.08%
2014-12-31 CN¥1.18 Billion
≈ $173.30 Million
CN¥52.00 Million
≈ $7.61 Million
0.044x +334.72%
2013-12-31 CN¥1.10 Billion
≈ $161.16 Million
CN¥-20.60 Million
≈ $-3.01 Million
-0.019x -142.66%
2012-12-31 CN¥1.02 Billion
≈ $148.60 Million
CN¥44.53 Million
≈ $6.52 Million
0.044x -90.38%
2011-12-31 CN¥304.42 Million
≈ $44.55 Million
CN¥138.83 Million
≈ $20.31 Million
0.456x +52.81%
2010-12-31 CN¥191.06 Million
≈ $27.96 Million
CN¥57.02 Million
≈ $8.34 Million
0.298x +257.54%
2009-12-31 CN¥140.43 Million
≈ $20.55 Million
CN¥-26.60 Million
≈ $-3.89 Million
-0.189x -136.16%
2008-12-31 CN¥79.34 Million
≈ $11.61 Million
CN¥41.57 Million
≈ $6.08 Million
0.524x --

About Yantai Dongcheng Pharmaceutical Co Ltd

SHE:002675 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.53 Billion
CN¥10.49 Billion CNY
Market Cap Rank
#7281 Global
#1671 in China
Share Price
CN¥12.72
Change (1 day)
+0.32%
52-Week Range
CN¥12.24 - CN¥18.29
All Time High
CN¥27.09
About

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti… Read more